Today: 29 April 2026
Browse Category

EBR:UCB 30 September 2025 - 27 April 2026

Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

Oruka Therapeutics reported its experimental psoriasis drug ORKA-001 achieved complete skin clearance in 63.5% of patients at 16 weeks. Shares jumped 10.5% to $76.39 before the company launched a $500 million public offering. No serious adverse events were reported in the trial. ORKA-001 is being developed as a long-acting injectable, with annual dosing possible.
27 April 2026
···
Euronext After the Bell: Eurozone Stocks End Mixed as Fed Rate-Cut Bets Cap Week of Gains (December 5, 2025)

Euronext After the Bell: Eurozone Stocks End Mixed as Fed Rate-Cut Bets Cap Week of Gains (December 5, 2025)

Euro Stoxx 50 rose 0.1% to 5,723.93, nearing its record high, while the Euronext 100 slipped 0.2% but stayed close to November peaks. France’s CAC 40 and Italy’s FTSE MIB ended flat to slightly lower; Belgium’s BEL 20 gained 0.33% on UCB strength. Investors watched U.S. PCE inflation data and awaited next week’s Federal Reserve meeting.
5 December 2025
··
European Stocks Climb Despite Shutdown Fears – Healthcare and Luxury Lead Gains

European Stocks Climb Despite Shutdown Fears – Healthcare and Luxury Lead Gains

The Stoxx 600 rose 0.18% to 555.53 on Sept. 29, with Germany’s DAX and the FTSE 100 also edging higher, while Italy’s FTSE MIB and Spain’s IBEX 35 slipped 0.22%. Euro-area economic confidence beat forecasts, and German import prices fell 1.5% year-on-year. Healthcare, luxury, and mining stocks gained; banks and energy lagged. GSK jumped on CEO news, while Carnival dropped 4.5% despite raising profit forecasts.
30 September 2025
······

Stock Market Today

  • Australian Stocks Dip as Inflation Hits Three-Year High, Fueling Rate Hike Concerns
    April 28, 2026, 11:39 PM EDT. Australia's stock market looks set for a seventh losing day as inflation climbs to a three-year peak of 4.6% year-on-year, driven by surging fuel prices amid the ongoing Iran conflict. The S&P/ASX 200 fell 0.12%, pressured by worries over global economic growth and expectations of an interest rate increase from the Reserve Bank, which targets 2-3% inflation but sees trimmed mean inflation steady at 3.3%. Energy sectors gained on soaring oil prices and OPEC tensions, while mining and financial stocks faced mixed performances. Concerns about the sustainability of AI investments emerged after disappointing results from OpenAI, unsettling tech-related stocks.

Latest article

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

29 April 2026
Oracle shares fell 4% and CoreWeave dropped 5.9% Tuesday after a Wall Street Journal report said OpenAI missed recent revenue and user targets. Nvidia, AMD, and Arm Holdings also declined, with the iShares Semiconductor ETF down 3.7%. OpenAI denied internal divisions and said its AI coding product Codex reached 4 million users. Oracle’s credit default swaps hit a two-week high amid concern over its $300 billion cloud deal with OpenAI.
Go toTop